Xu H - Search Results

1

Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients.

Li H, Wang Z, Xiao W, Yan L, Guan W, Hu Z, Wu L, Huang Q, Wang J, Xu H, Zhang X, Ye Z. Li H, et al. Among authors: xu h. Mod Pathol. 2018 Jan;31(1):198-208. doi: 10.1038/modpathol.2017.74. Epub 2017 Oct 27. Mod Pathol. 2018. PMID: 29076496 Free article.

2

DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.

Ma X, Xu H, Zheng T, Li HZ, Shi TP, Wang BJ, Ju ZH, Wang C, Zhang GX, Zhang X. Ma X, et al. Among authors: xu h. BJU Int. 2008 Aug 5;102(5):633-6. doi: 10.1111/j.1464-410X.2008.07634.x. Epub 2008 Apr 2. BJU Int. 2008. PMID: 18384629

3

Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor.

Hu J, Li H, Shi T, Ma X, Wang B, Xu H, Ai X, Ju Z, Wang C, Zhang G, Zhang X. Hu J, et al. Among authors: xu h. J Huazhong Univ Sci Technolog Med Sci. 2008 Apr;28(2):182-4. doi: 10.1007/s11596-008-0217-3. Epub 2008 May 15. J Huazhong Univ Sci Technolog Med Sci. 2008. PMID: 18480993

4

Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival.

Shi TP, Xu H, Wei JF, Ai X, Ma X, Wang BJ, Ju ZH, Zhang GX, Wang C, Wu ZQ, Zhang X. Shi TP, et al. Among authors: xu h. J Urol. 2008 Jul;180(1):361-6. doi: 10.1016/j.juro.2008.02.037. Epub 2008 May 21. J Urol. 2008. PMID: 18499162

5

LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.

Li F, Yang W, Guo D, Hu Z, Xu H, Ye Z. Li F, et al. Among authors: xu h. Oncol Rep. 2011 Jun;25(6):1629-37. doi: 10.3892/or.2011.1227. Epub 2011 Mar 22. Oncol Rep. 2011. PMID: 21431282

6

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.

Li H, Yu G, Shi R, Lang B, Chen X, Xia D, Xiao H, Guo X, Guan W, Ye Z, Xiao W, Xu H. Li H, et al. Among authors: xu h. Mol Cancer. 2014 Jan 15;13:8. doi: 10.1186/1476-4598-13-8. Mol Cancer. 2014. PMID: 24423412 Free PMC article.

7

MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.

Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K, Zeng J, He W, Zeng G, Ye Z, Xu H. Xiao H, et al. Among authors: xu h. Oncol Rep. 2014 Apr;31(4):1832-8. doi: 10.3892/or.2014.3048. Epub 2014 Feb 24. Oncol Rep. 2014. PMID: 24573354

8

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.

Lipianskaya J, Cohen A, Chen CJ, Hsia E, Squires J, Li Z, Zhang Y, Li W, Chen X, Xu H, Huang J. Lipianskaya J, et al. Among authors: xu h. Asian J Androl. 2014 Jul-Aug;16(4):541-4. doi: 10.4103/1008-682X.123669. Asian J Androl. 2014. PMID: 24589459 Free PMC article. Review.

9

Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies.

Tang K, Li H, Xia D, Hu Z, Zhuang Q, Liu J, Xu H, Ye Z. Tang K, et al. Among authors: xu h. PLoS One. 2014 May 16;9(5):e95667. doi: 10.1371/journal.pone.0095667. eCollection 2014. PLoS One. 2014. PMID: 24835573 Free PMC article. Review.

10

miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells.

Yu G, Li H, Wang J, Gumireddy K, Li A, Yao W, Tang K, Xiao W, Hu J, Xiao H, Lang B, Ye Z, Huang Q, Xu H. Yu G, et al. Among authors: xu h. J Urol. 2014 Oct;192(4):1229-37. doi: 10.1016/j.juro.2014.05.094. Epub 2014 May 24. J Urol. 2014. PMID: 24866595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,561 results

Search Page

Filters